HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Benedetti Selected Research

Amino Acid Transport System X-AG (Glutamate Transporter)

1/2019White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress.
8/2018A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder.
6/2014Effect of early stress on hippocampal gray matter is influenced by a functional polymorphism in EAAT2 in bipolar disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Benedetti Research Topics

Disease

63Bipolar Disorder (Manic Depressive Psychosis)
12/2022 - 06/2003
40Sleep Deprivation
12/2022 - 10/2002
22Mood Disorders (Mood Disorder)
12/2022 - 02/2002
12COVID-19
05/2022 - 01/2020
11Major Depressive Disorder (Major Depressive Disorders)
11/2021 - 06/2003
9Inflammation (Inflammations)
01/2022 - 09/2016
7Schizophrenia (Dementia Praecox)
01/2022 - 10/2009
7Depressive Disorder (Melancholia)
01/2022 - 12/2007
7Mania (Manias)
01/2021 - 02/2005
6Mental Disorders (Mental Disorder)
01/2022 - 01/2018
4Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
10/2020 - 01/2009
3Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 09/2004
2Obesity
01/2022 - 06/2021
2Hypoxia (Hypoxemia)
01/2022 - 10/2021
2Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 06/2021
2Neuroinflammatory Diseases
01/2022 - 01/2020
2Demyelinating Diseases (Demyelinating Disease)
11/2014 - 08/2012
2Sleep Initiation and Maintenance Disorders (Insomnia)
08/2005 - 09/2004
1Anxiety Disorders (Anxiety Disorder)
01/2022
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022
1Post-Acute COVID-19 Syndrome
01/2022
1Genetic Risk Score
01/2021
1Infections
10/2020
1Breast Neoplasms (Breast Cancer)
01/2018
1Wounds and Injuries (Trauma)
08/2017
1Borderline Personality Disorder (Personality Disorders, Borderline)
01/2017

Drug/Important Bio-Agent (IBA)

48Antidepressive Agents (Antidepressants)IBA
12/2022 - 10/2002
18Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2014
16Pharmaceutical PreparationsIBA
12/2022 - 10/2002
12LithiumIBA
01/2022 - 12/2005
11CytokinesIBA
01/2022 - 09/2016
9Biological ProductsIBA
12/2022 - 01/2007
7Glutamic Acid (Glutamate)FDA Link
12/2022 - 09/2009
5Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2020 - 02/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2021 - 09/2016
4N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
01/2019 - 11/2014
4Serotonin (5 Hydroxytryptamine)IBA
03/2018 - 01/2007
4Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
02/2013 - 02/2010
4Glycogen Synthase KinasesIBA
03/2008 - 01/2004
3Tryptophan (L-Tryptophan)FDA Link
01/2022 - 03/2018
3KynurenineIBA
01/2022 - 03/2018
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 06/2003
3Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2019 - 06/2014
3SaltsIBA
10/2012 - 12/2005
3Dopamine (Intropin)FDA LinkGeneric
07/2011 - 01/2007
2Vitamin DFDA LinkGeneric
01/2022 - 01/2016
2Fluvoxamine (Luvox)FDA LinkGeneric
01/2022 - 01/2004
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2022 - 09/2007
2CholesterolIBA
12/2021 - 11/2016
2Interleukin-6 (Interleukin 6)IBA
12/2021 - 10/2002
2Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2018
2ChemokinesIBA
01/2021 - 01/2021
2Protons (Proton)IBA
01/2020 - 11/2016
2Transcription Factors (Transcription Factor)IBA
10/2018 - 01/2015
2Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2017 - 01/2016
2Becaplermin (PDGF-BB)FDA Link
09/2016 - 01/2016
2ElementsIBA
01/2015 - 02/2013
2Glycogen Synthase Kinase 3IBA
01/2013 - 02/2012
1ZincIBA
01/2022
1AntioxidantsIBA
01/2022
1AshwagandhaIBA
01/2022
1CurcuminIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Glutathione (Reduced Glutathione)IBA
01/2022
1MicronutrientsIBA
01/2022
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2022
1Acetylcarnitine (Alcar)IBA
01/2022
1Methionine (L-Methionine)FDA Link
01/2022
1Therapeutic UsesIBA
01/2022
1AdiponectinIBA
11/2021
1Drug CombinationsIBA
11/2021
1EscitalopramFDA Link
11/2021
1KetamineFDA LinkGeneric
11/2021
1AlarminsIBA
10/2021
1lactate dehydrogenase C4IBA
10/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021
1IronIBA
10/2021
1CreatinineIBA
10/2021
1AdipokinesIBA
10/2021
1C-Reactive ProteinIBA
06/2021
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1VaccinesIBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1Kynurenic Acid (Kynurenate)IBA
03/2018
1DioxygenasesIBA
03/2018
1Homer Scaffolding Proteins (Homer 1)IBA
02/2018
1Sterol Regulatory Element Binding ProteinsIBA
11/2016
1LipidsIBA
11/2016
1Interleukin-8 (Interleukin 8)IBA
09/2016
1Interleukin-10 (Interleukin 10)IBA
09/2016

Therapy/Procedure

31Phototherapy (Light Therapy)
12/2022 - 10/2003
11Therapeutics
05/2022 - 09/2004
2Aftercare (After-Treatment)
12/2022 - 01/2021
2Chronotherapy
01/2020 - 12/2019
2Transcranial Magnetic Stimulation
12/2014 - 01/2009
1Noninvasive Ventilation
01/2022
1Length of Stay
06/2021
1Drug Therapy (Chemotherapy)
01/2018
1Surgical Instruments (Clip)
09/2016